APA (7th ed.) Citation

Repin, A. N., Sergienko, T. N., Muslimova, E. F., & Afanasyev, E. F. (2015). GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Repin, A. N., T. N. Sergienko, E. F. Muslimova, and E. F. Afanasyev. GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES. «FIRMA «SILICEA» LLC, 2015.

MLA (9th ed.) Citation

Repin, A. N., et al. GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES. «FIRMA «SILICEA» LLC, 2015.